Peptide therapies have surged in the U.S., propelled by influencers, celebrity podcasters and the growth of an online gray market. Millions are self‑administering unapproved peptides sourced from forums and unregulated suppliers, often without medical advice. Experts warn of limited human evidence, manufacturing and contamination risks, and potential harms such as angiogenesis‑related concerns. The AMA has urged stronger FDA oversight while debate continues over access to experimental treatments.
Peptide Craze Grips the U.S.: How Influencers Are Reshaping Healthcare Choices
Peptide therapy is popular, thanks in part to the Trump administration's more liberal policy on these treatments. (Photo by Smith Collection/Gado/Getty Images)Gado via Getty Images
Peptide therapies have surged in popularity across the United States, driven largely by wellness influencers, celebrity podcasters and a permissive regulatory environment in recent years. Millions of Americans are reportedly obtaining and self-administering unapproved peptide products sourced from online forums and gray‑market suppliers rather than following clinical guidance.
Why Peptides Appeal
Peptides are short chains of amino acids that act as building blocks for proteins and as intercellular signaling molecules. Some are well-established medicines—insulin for diabetes and GLP‑1 drugs such as Ozempic and Wegovy are regulated therapies taken by millions. But many other peptides, including popular compounds touted online, lack robust human clinical data.
The Role of Influencers and the 'Do Your Own Research' Mindset
Roughly half of Americans under 50 say they get health information from wellness influencers, according to surveys cited in reporting on the trend. A libertarian‑tinged "do your own research" ethos encourages people to try alternative remedies promoted by influencers and decide independently which treatments to pursue. That culture has contributed to self‑treatment with substances ranging from ivermectin and psilocybin to various peptide preparations—often without medical supervision.
Popular Peptides and Their Risks
BPC‑157, a synthetic peptide derived from a peptide fragment in gastric juice, is one of the compounds most frequently promoted by podcasters and wellness accounts. Advocates claim it accelerates tissue healing and gut repair. However, human evidence is limited to a few small studies and anecdotal reports. Scientists have also warned about biological risks associated with some peptides—most notably angiogenesis, the growth of new blood vessels, which can be beneficial for healing but may also support tumor growth and metastasis.
Other risks include allergic reactions, incorrect dosing, contaminated or impure products from unregulated suppliers, and dangerous interactions when combined with other substances. Compounded or gray‑market peptide products often escape standard manufacturing oversight, raising safety concerns.
Regulatory Response and Debate
At the American Medical Association's annual meeting, delegates urged the Food and Drug Administration to strengthen oversight of unapproved synthetic peptides and to require rigorous review and clinical trials for products currently circulating in a largely unregulated market. The FDA has historically cautioned against using unapproved peptides because of limited clinical data and manufacturing risks.
Separately, prominent public figures and proponents of alternative‑health approaches have called for loosening restrictions on some experimental treatments. Those positions have amplified debate about how to balance access to new therapies with the need for proven safety and efficacy.
What Patients Should Know
Consumers considering peptide therapies should consult licensed healthcare professionals, seek evidence from well‑conducted clinical trials, and be wary of anecdote‑driven claims from social media. When treatments are obtained outside regulated channels, the potential harms—ranging from contamination to serious biological effects—can outweigh unproven benefits.
For further context, journalist Sara Talpos’ investigation in Undark traces the science, history and contemporary promotion of peptide therapies and highlights both their promise and the gaps in human evidence for many widely promoted compounds.
Bottom line: Peptides include both approved, life‑saving medicines and experimental compounds promoted online. Greater regulatory oversight and better public education are needed to protect patients from unsafe or unproven products promoted outside clinical practice.
Help us improve.
